WASHINGTON, D.C. — Federal regulators are moving to reduce the use of animal testing in drug development, issuing new ...
Non-animal testing methods could save drugmakers time and money, officials say ...
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward ...
FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...
Early 2026 has brought a series of consequential regulatory moves from the FDA, each reflecting a common thread: the agency ...
The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...
The ambitious task on hand is apparent from the weighty title of the report – ‘Landscape Analysis on Alternatives to Animal Testing for Drug Development in India.’ That the report has the foreword by ...